» Articles » PMID: 39724301

Modification of Fc-fusion Protein Structures to Enhance Efficacy of Cancer Vaccine in Plant Expression System

Overview
Specialties Biology
Biotechnology
Date 2024 Dec 26
PMID 39724301
Authors
Affiliations
Soon will be listed here.
Abstract

Epithelial cell adhesion molecule (EpCAM) fused to IgG, IgA and IgM Fc domains was expressed to create IgG, IgA and IgM-like structures as anti-cancer vaccines in Nicotiana tabacum. High-mannose glycan structures were generated by adding a C-terminal endoplasmic reticulum (ER) retention motif (KDEL) to the Fc domain (FcK) to produce EpCAM-Fc and EpCAM-FcK proteins in transgenic plants via Agrobacterium-mediated transformation. Cross-fertilization of EpCAM-Fc (FcK) transgenic plants with Joining chain (J-chain, J and JK) transgenic plants led to stable expression of large quaternary EpCAM-IgA Fc (EpCAM-A) and IgM-like (EpCAM-M) proteins. Immunoblotting, SDS-PAGE and ELISA analyses demonstrated that proteins with KDEL had higher expression levels and binding activity to anti-EpCAM IgGs. IgM showed the strongest binding among the fusion proteins, followed by IgA and IgG. Sera from BALB/c mice immunized with these vaccines produced anti-EpCAM IgGs. Flow cytometry indicated that the EpCAM-Fc fusion proteins significantly activated CD8 cytotoxic T cells, CD4 helper T cells and B cells, particularly with EpCAM-FcK and EpCAM-Fc (FcK) × J (JK). The induced anti-EpCAM IgGs captured human prostate cancer PC-3 and colorectal cancer SW620 cells. Sera from immunized mice inhibited cancer cell proliferation, migration and invasion; down-regulated proliferation markers (PCNA, Ki-67) and epithelial-mesenchymal transition markers (Vimentin); and up-regulated E-cadherin. These findings suggest that N. tabacum can produce effective vaccine candidates to induce anti-cancer immune responses.

Citing Articles

Plant cross-fertilization for production of dual-specific antibodies targeting both Ebola virus-like particles and HER2 protein in F plants.

Lee D, Hwang H, Kim Y, Hwang Y, Youk K, Hinterdorfer P Genes Genomics. 2025; .

PMID: 39849191 DOI: 10.1007/s13258-025-01616-z.

References
1.
Wong-Arce A, Gonzalez-Ortega O, Rosales-Mendoza S . Plant-Made Vaccines in the Fight Against Cancer. Trends Biotechnol. 2017; 35(3):241-256. DOI: 10.1016/j.tibtech.2016.12.002. View

2.
Lim C, Kim D, Kang Y, Lee Y, Kim K, Kim D . Immune Responses to Plant-Derived Recombinant Colorectal Cancer Glycoprotein EpCAM-FcK Fusion Protein in Mice. Biomol Ther (Seoul). 2022; 30(6):546-552. PMC: 9622315. DOI: 10.4062/biomolther.2022.103. View

3.
Ammann J, Trowsdale J . Development and use of IgM/J-chain fusion proteins for characterization of immunoglobulin superfamily ligand-receptor interactions. Curr Protoc Protein Sci. 2014; 75:19.24.1-19.24.11. DOI: 10.1002/0471140864.ps1924s75. View

4.
Rao C, Chianese D, Doyle G, Miller M, Russell T, Sanders Jr R . Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors. Int J Oncol. 2005; 27(1):49-57. View

5.
Mekhaiel D, Czajkowsky D, Andersen J, Shi J, El-Faham M, Doenhoff M . Polymeric human Fc-fusion proteins with modified effector functions. Sci Rep. 2012; 1:124. PMC: 3216605. DOI: 10.1038/srep00124. View